Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available - Drugs.com MedNews

Links shared publicly online about this topic.

  • 1,240
    total visits

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available - Drugs.com MedNews

drugs.com

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out Alternative Treatments Available The U.S. Food and Drug Administration today announc

View full resource at drugs.com

Tags: Asthma, COPD, Drug, FDA

  • Share

Most Recently Shared on April 14, 2010 at 11:08 pm By:

drugscom Drugs.com

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out - http://bit.ly/cxfAoj

2 years ago...

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available

dld.bz — “The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. AlternView full resource at dld.bz

  • View Related
  • Share

Most Recently Shared on April 26, 2010 at 3:01 pm By:

drchacko Northside Allergy Doctor, Internist, Allergist, and Physician

Great tie into last week's earth day: FDA to remove asthma inhalers that deplete the Ozone layer.---> http://dld.bz/bvTh. Pls RT

2 years ago...

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available

fda.gov — “The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. AlternView full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on April 13, 2010 at 8:40 pm By:

eyeonfda eyeonfda Health Lawyer and Pharma

FDA - Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out http://ow.ly/1y46M

2 years ago...

Advertisement